Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia
The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial...
Brief Summary
Official Title: “Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia”
The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia
- Study Type: Interventional
- Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
- Study Primary Completion Date: March 2005
Intervention(s) in this Clinical Trial
- Drug: Fluvastatin
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- 10-16 years old Heterozygous familial hypercholesterolemia
Exclusion Criteria:
- Homozygous familial hypercholesterolemia Pregnant or lactating females Major surgery during the six month prior study
- Other protocol defined inclusion and exclusion criteria may apply
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 10 Years
Maximum Age for this Clinical Trial: 16 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Novartis Industry
Overall Clinical Trial Officials and Contacts
Novartis Pharmaceuticals Study Director Novartis Pharmaceuticals
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00171236
Study ID Number: CXUO320B2301
ClinicalTrials.gov Identifier: NCT00171236
Health Authority: Netherlands: Medicines Evaluation Board (MEB)
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00171236
